| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
Review |
Laboratoire d' Oncologie Virale et Moléculaire, UFR de Biochimie, Université Paris 7-D. Diderot, 2 Place Jussieu, 75 005 Paris, France
Correspondence: Professor Perbal bernard.perbal{at}wanadoo.fr
The CCN family of genes presently consists of six distinct members encoding proteins that participate in fundamental biological processes such as cell proliferation, attachment, migration, differentiation, wound healing, angiogenesis, and several pathologies including fibrosis and tumorigenesis. Whereas CYR61 and CTGF were reported to act as positive regulators of cell growth, NOV (nephroblastoma overexpressed) provided the first example of a CCN protein with negative regulatory properties and the first example of aberrant expression being associated with tumour development. The subsequent discovery of the ELM1, rCOP1, and WISP proteins has broadened the variety of functions attributed to the CCN proteins and has extended previous observations to other biological systems. This review discusses fundamental questions regarding the regulation of CCN gene expression in normal and pathological conditions, and the structural basis for their specific biological activity. After discussing the role of nov and other CCN proteins in the development of a variety of different tissues such as kidney, nervous system, muscle, cartilage, and bone, the altered expression of the CCN proteins in various pathologies is discussed, with an emphasis on the altered expression of nov in many different tumour types such as Wilms's tumour, renal cell carcinomas, prostate carcinomas, osteosarcomas, chondrosarcomas, adrenocortical carcinomas, and neuroblastomas. The possible use of nov as a tool for molecular medicine is also discussed. The variety of biological functions attributed to the CCN proteins has led to the proposal of a model in which physical interactions between the amino and carboxy portions of the CCN proteins modulate their biological activity and ensure a proper balance of positive and negative signals through interactions with other partners. In this model, disruption of the secondary structure of the CCN proteins induced by deletions of either terminus is expected to confer on the truncated polypeptide constitutive positive or negative activities.
Key Words: cancer • differentiation • signalling • development • angiogenesis • fibrosis • ctgf • cyr61 • wisp • CCN
This article has been cited by other articles:
|
|
 |
|
  W. Huang, Y. Zhang, S. Varambally, A. M. Chinnaiyan, M. Banerjee, S. D. Merajver, and C. G. Kleer Inhibition of CCN6 (Wnt-1-Induced Signaling Protein 3) Down-Regulates E-Cadherin in the Breast Epithelium through Induction of Snail and ZEB1 Am. J. Pathol., April 1, 2008; 172(4): 893 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Vallacchi, M. Daniotti, F. Ratti, D. Di Stasi, P. Deho, A. De Filippo, G. Tragni, A. Balsari, A. Carbone, L. Rivoltini, et al. CCN3/Nephroblastoma Overexpressed Matricellular Protein Regulates Integrin Expression, Adhesion, and Dissemination in Melanoma Cancer Res., February 1, 2008; 68(3): 715 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Perbal, M. Zuntini, D. Zambelli, M. Serra, M. Sciandra, L. Cantiani, E. Lucarelli, P. Picci, and K. Scotlandi Prognostic Value of CCN3 in Osteosarcoma Clin. Cancer Res., February 1, 2008; 14(3): 701 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Z. Deng, P.-P. Chen, Y. Wang, D. Yin, H. P. Koeffler, B. Li, X.-J. Tong, and D. Xie Connective Tissue Growth Factor Is Overexpressed in Esophageal Squamous Cell Carcinoma and Promotes Tumorigenicity through -Catenin-T-cell Factor/Lef Signaling J. Biol. Chem., December 14, 2007; 282(50): 36571 - 36581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kikuchi, H. Tsuda, Y. Kanai, T. Kasamatsu, K. Sengoku, S. Hirohashi, J. Inazawa, and I. Imoto Promoter Hypermethylation Contributes to Frequent Inactivation of a Putative Conditional Tumor Suppressor Gene Connective Tissue Growth Factor in Ovarian Cancer Cancer Res., August 1, 2007; 67(15): 7095 - 7105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Yan, R. C. Baxter, B. Perbal, and S. M. Firth The Aminoterminal Insulin-Like Growth Factor (IGF) Binding Domain of IGF Binding Protein-3 Cannot Be Functionally Substituted by the Structurally Homologous Domain of CCN3 Endocrinology, November 1, 2006; 147(11): 5268 - 5274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. McCallum, S. Price, N. Planque, B. Perbal, A. Pierce, A. D. Whetton, and A. E. Irvine A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation Blood, September 1, 2006; 108(5): 1716 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen, H. Ni, X.-H. Ma, S.-J. Hu, L.-M. Luan, G. Ren, Y.-C. Zhao, S.-J. Li, H.-L. Diao, X. Xu, et al. Global analysis of differential luminal epithelial gene expression at mouse implantation sites. J. Mol. Endocrinol., August 1, 2006; 37(1): 147 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Chien, D. Yin, D. Gui, A. Mori, J. M. Frank, J. Said, D. Kusuanco, A. Marchevsky, R. McKenna, and H. P. Koeffler Suppression of Cell Proliferation and Signaling Transduction by Connective Tissue Growth Factor in Non-Small Cell Lung Cancer Cells Mol. Cancer Res., August 1, 2006; 4(8): 591 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gellhaus, M. Schmidt, C. Dunk, S. J. Lye, R. Kimmig, and E. Winterhager Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associatedwith pre-eclampsia Mol. Hum. Reprod., June 1, 2006; 12(6): 389 - 399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Huang, L. Taylor, B. Liu, J. Yu, and P. Polgar Modulation by bradykinin of angiotensin type 1 receptor-evoked RhoA activation of connective tissue growth factor expression in human lung fibroblasts Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1291 - L1299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Aikawa, J. Gunn, S. M. Spong, S. J. Klaus, and M. Korc Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer Mol. Cancer Ther., May 1, 2006; 5(5): 1108 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Luo, L. Ding, and N. Chegini CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-{beta} and regulation by TGF-{beta} in leiomyoma and myometrial smooth muscle cells Mol. Hum. Reprod., April 1, 2006; 12(4): 245 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-Y. Tong and D. R Brigstock Intrinsic biological activity of the thrombospondin structural homology repeat in connective tissue growth factor. J. Endocrinol., March 1, 2006; 188(3): R1 - R8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Burgess, Q. Ge, M. H. Poniris, S. Boustany, S. M. Twigg, J. L. Black, and P. R. A. Johnson Connective tissue growth factor and vascular endothelial growth factor from airway smooth muscle interact with the extracellular matrix Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L153 - L161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Grotendorst and M. R. Duncan Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation FASEB J, May 1, 2005; 19(7): 729 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Lin, C.-C. Chen, S.-J. Leu, T. M. Grzeszkiewicz, and L. F. Lau Integrin-dependent Functions of the Angiogenic Inducer NOV (CCN3): IMPLICATION IN WOUND HEALING J. Biol. Chem., March 4, 2005; 280(9): 8229 - 8237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. E. Kutz, Y. Gong, and M. L. Warman WISP3, the Gene Responsible for the Human Skeletal Disease Progressive Pseudorheumatoid Dysplasia, Is Not Essential for Skeletal Function in Mice Mol. Cell. Biol., January 1, 2005; 25(1): 414 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Chien, T. Kumagai, C. W. Miller, J. C. Desmond, J. M. Frank, J. W. Said, and H. P. Koeffler Cyr61 Suppresses Growth of Human Endometrial Cancer Cells J. Biol. Chem., December 17, 2004; 279(51): 53087 - 53096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen, D. J. Abraham, X. Shi-wen, J. D. Pearson, C. M. Black, K. M. Lyons, and A. Leask CCN2 (Connective Tissue Growth Factor) Promotes Fibroblast Adhesion to Fibronectin Mol. Biol. Cell, December 1, 2004; 15(12): 5635 - 5646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Chen, S.-J. Leu, V. Todorovic, S. C.-T. Lam, and L. F. Lau Identification of a Novel Integrin {alpha}v{beta}3 Binding Site in CCN1 (CYR61) Critical for Pro-angiogenic Activities in Vascular Endothelial Cells J. Biol. Chem., October 15, 2004; 279(42): 44166 - 44176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Leu, N. Chen, C.-C. Chen, V. Todorovic, T. Bai, V. Juric, Y. Liu, G. Yan, S. C.-T. Lam, and L. F. Lau Targeted Mutagenesis of the Angiogenic Protein CCN1 (CYR61): SELECTIVE INACTIVATION OF INTEGRIN {alpha}6{beta}1-HEPARAN SULFATE PROTEOGLYCAN CORECEPTOR-MEDIATED CELLULAR FUNCTIONS J. Biol. Chem., October 15, 2004; 279(42): 44177 - 44187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Williams, J. P. Mear, H.-C. Liang, S. S. Potter, B. J. Aronow, and M. C. Colbert Large-scale reprogramming of cranial neural crest gene expression by retinoic acid exposure Physiol Genomics, October 4, 2004; 19(2): 184 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. French, R. J. Kaul, A. L. D'Souza, C. W. Crowley, M. Bao, G. D. Frantz, E. H. Filvaroff, and L. Desnoyers WISP-1 Is an Osteoblastic Regulator Expressed During Skeletal Development and Fracture Repair Am. J. Pathol., September 1, 2004; 165(3): 855 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gellhaus, X. Dong, S. Propson, K. Maass, L. Klein-Hitpass, M. Kibschull, O. Traub, K. Willecke, B. Perbal, S. J. Lye, et al. Connexin43 Interacts with NOV: A POSSIBLE MECHANISM FOR NEGATIVE REGULATION OF CELL GROWTH IN CHORIOCARCINOMA CELLS J. Biol. Chem., August 27, 2004; 279(35): 36931 - 36942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hilfiker-Kleiner, K. Kaminski, A. Kaminska, M. Fuchs, G. Klein, E. Podewski, K. Grote, I. Kiian, K. C. Wollert, A. Hilfiker, et al. Regulation of Proangiogenic Factor CCN1 in Cardiac Muscle: Impact of Ischemia, Pressure Overload, and Neurohumoral Activation Circulation, May 11, 2004; 109(18): 2227 - 2233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Trackman and A. Kantarci CONNECTIVE TISSUE METABOLISM AND GINGIVAL OVERGROWTH Crit. Rev. Oral. Biol. Med., May 1, 2004; 15(3): 165 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Hennebold Characterization of the ovarian transcriptome through the use of differential analysis of gene expression methodologies Hum. Reprod. Update, May 1, 2004; 10(3): 227 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mercurio, B. Latinkic, N. Itasaki, R. Krumlauf, and J. C. Smith Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex Development, May 1, 2004; 131(9): 2137 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Croci, L. Landuzzi, A. Astolfi, G. Nicoletti, A. Rosolen, F. Sartori, M. Y. Follo, N. Oliver, C. De Giovanni, P. Nanni, et al. Inhibition of Connective Tissue Growth Factor (CTGF/CCN2) Expression Decreases the Survival and Myogenic Differentiation of Human Rhabdomyosarcoma Cells Cancer Res., March 1, 2004; 64(5): 1730 - 1736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Hinton, C. Spee, S. He, S. Weitz, W. Usinger, L. LaBree, N. Oliver, and J. I. Lim Accumulation of NH2-Terminal Fragment of Connective Tissue Growth Factor in the Vitreous of Patients With Proliferative Diabetic Retinopathy Diabetes Care, March 1, 2004; 27(3): 758 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Minato, S. Kubota, H. Kawaki, T. Nishida, A. Miyauchi, H. Hanagata, T. Nakanishi, T. Takano-Yamamoto, and M. Takigawa Module-Specific Antibodies against Human Connective Tissue Growth Factor: Utility for Structural and Functional Analysis of the Factor as Related to Chondrocytes J. Biochem., March 1, 2004; 135(3): 347 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Mason, A. C. Lake, J. E. Wubben, R. A. Nowak, and J. J. Castellot Jr The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells Mol. Hum. Reprod., March 1, 2004; 10(3): 181 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Mason, D. Grove-Strawser, B. S. Rubin, R. A. Nowak, and J. J. Castellot Jr. Estrogen Induces CCN5 Expression in the Rat Uterus in Vivo Endocrinology, February 1, 2004; 145(2): 976 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bruno, R. Hoffmann, F. McBlane, J. Brown, R. Gupta, C. Joshi, S. Pearson, T. Seidl, C. Heyworth, and T. Enver Molecular Signatures of Self-Renewal, Differentiation, and Lineage Choice in Multipotential Hemopoietic Progenitor Cells In Vitro Mol. Cell. Biol., January 15, 2004; 24(2): 741 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sakamoto, M. Yokoyama, K. Prakash, J.-I. Tsuruha, S. Masamoto, R. H. Getzenberg, and Y. Kakehi Development of Quantitative Detection Assays for CYR61 as a New Marker for Benign Prostatic Hyperplasia J Biomol Screen, December 1, 2003; 8(6): 701 - 711. [Abstract] [PDF]
|
|
|
|
|
|
M. Kunz, S. Moeller, D. Koczan, P. Lorenz, R. H. Wenger, M. O. Glocker, H.-J. Thiesen, G. Gross, and S. M. Ibrahim Mechanisms of Hypoxic Gene Regulation of Angiogenesis Factor Cyr61 in Melanoma Cells J. Biol. Chem., November 14, 2003; 278(46): 45651 - 45660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Iwanciw, M. Rehm, M. Porst, and M. Goppelt-Struebe Induction of Connective Tissue Growth Factor by Angiotensin II: Integration of Signaling Pathways Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1782 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Leu, Y. Liu, N. Chen, C.-C. Chen, S. C.-T. Lam, and L. F. Lau Identification of a Novel Integrin {alpha}6{beta}1 Binding Site in the Angiogenic Inducer CCN1 (CYR61) J. Biol. Chem., September 5, 2003; 278(36): 33801 - 33808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. He, M. L. Jin, V. Worpel, and D. R. Hinton A Role for Connective Tissue Growth Factor in the Pathogenesis of Choroidal Neovascularization Arch Ophthalmol, September 1, 2003; 121(9): 1283 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Schober, L. F. Lau, T. P. Ugarova, and S. C.-T. Lam Identification of a Novel Integrin {alpha}M{beta}2 Binding Site in CCN1 (CYR61), a Matricellular Protein Expressed in Healing Wounds and Atherosclerotic Lesions J. Biol. Chem., July 3, 2003; 278(28): 25808 - 25815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ratcliffe, M. Nakanishi, and R. B. Jaffe Identification of Definitive and Fetal Zone Markers in the Human Fetal Adrenal Gland Reveals Putative Developmental Genes J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3272 - 3277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Lin, S.-J. Leu, N. Chen, C. M. Tebeau, S.-X. Lin, C.-Y. Yeung, and L. F. Lau CCN3 (NOV) Is a Novel Angiogenic Regulator of the CCN Protein Family J. Biol. Chem., June 20, 2003; 278(26): 24200 - 24208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ivkovic, B. S. Yoon, S. N. Popoff, F. F. Safadi, D. E. Libuda, R. C. Stephenson, A. Daluiski, and K. M. Lyons Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development Development, June 15, 2003; 130(12): 2779 - 2791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Perbal, D R Brigstock, and L F Lau Report on the second international workshop on the CCN family of genes Mol. Pathol., April 1, 2003; 56(2): 80 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D R Brigstock, R Goldschmeding, K-i Katsube, S C-T Lam, L F Lau, K Lyons, C Naus, B Perbal, B Riser, M Takigawa, et al. Proposal for a unified CCN nomenclature Mol. Pathol., April 1, 2003; 56(2): 127 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Soon, T.-A. Yie, A. Shvarts, A. J. Levine, F. Su, and K.-M. Tchou-Wong Overexpression of WISP-1 Down-regulated Motility and Invasion of Lung Cancer Cells through Inhibition of Rac Activation J. Biol. Chem., March 21, 2003; 278(13): 11465 - 11470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-E Mo, A. G. Muntean, C.-C. Chen, D. B. Stolz, S. C. Watkins, and L. F. Lau CYR61 (CCN1) Is Essential for Placental Development and Vascular Integrity Mol. Cell. Biol., December 15, 2002; 22(24): 8709 - 8720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Leu, S. C.-T. Lam, and L. F. Lau Pro-angiogenic Activities of CYR61 (CCN1) Mediated through Integrins alpha vbeta 3 and alpha 6beta 1 in Human Umbilical Vein Endothelial Cells J. Biol. Chem., November 22, 2002; 277(48): 46248 - 46255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. McCaig, C. M. Perks, and J. M. P. Holly Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin J. Cell Sci., November 15, 2002; 115(22): 4293 - 4303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hu, J. E. Ippolito, E. M. Garabedian, P. A. Humphrey, and J. I. Gordon Molecular Characterization of a Metastatic Neuroendocrine Cell Cancer Arising in the Prostates of Transgenic Mice J. Biol. Chem., November 8, 2002; 277(46): 44462 - 44474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Chaqour, C. Whitbeck, J.-S. Han, E. Macarak, P. Horan, P. Chichester, and R. Levin Cyr61 and CTGF are molecular markers of bladder wall remodeling after outlet obstruction Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E765 - E774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sakamoto, S. Yamaguchi, R. Ando, A. Miyawaki, Y. Kabasawa, M. Takagi, C. L. Li, B. Perbal, and K.-i. Katsube The Nephroblastoma Overexpressed Gene (NOV/ccn3) Protein Associates with Notch1 Extracellular Domain and Inhibits Myoblast Differentiation via Notch Signaling Pathway J. Biol. Chem., August 9, 2002; 277(33): 29399 - 29405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C L Li, V Martinez, B He, A Lombet, and B Perbal A role for CCN3 (NOV) in calcium signalling Mol. Pathol., August 1, 2002; 55(4): 250 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hilfiker, D. Hilfiker-Kleiner, M. Fuchs, K. Kaminski, A. Lichtenberg, H.-J. Rothkotter, B. Schieffer, and H. Drexler Expression of CYR61, an Angiogenic Immediate Early Gene, in Arteriosclerosis and Its Regulation by Angiotensin II Circulation, July 9, 2002; 106(2): 254 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E E-D A Moussad, M A E Rageh, A K Wilson, R D Geisert, and D R Brigstock Temporal and spatial expression of connective tissue growth factor (CCN2; CTGF) and transforming growth factor {beta} type 1 (TGF-{beta}1) at the utero-placental interface during early pregnancy in the pig Mol. Pathol., June 1, 2002; 55(3): 186 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Manara, B. Perbal, S. Benini, R. Strammiello, V. Cerisano, S. Perdichizzi, M. Serra, A. Astolfi, F. Bertoni, J. Alami, et al. The Expression of ccn3(nov) Gene in Musculoskeletal Tumors Am. J. Pathol., March 1, 2002; 160(3): 849 - 859. |
